Global Medical REIT Inc. (GMRE)
| Market Cap | 638.49M |
| Revenue (ttm) | 89.25M |
| Net Income (ttm) | -7.60M |
| Shares Out | 46.91M |
| EPS (ttm) | -0.17 |
| PE Ratio | n/a |
| Forward PE | 58.48 |
| Dividend | $0.80 |
| Dividend Yield | 6.05% |
| Trading Day | January 21 |
| Last Price | $13.22 |
| Previous Close | $13.25 |
| Change ($) | -0.03 |
| Change (%) | -0.23% |
| Day's Open | 13.19 |
| Day's Range | 12.95 - 13.26 |
| Day's Volume | 274,067 |
| 52-Week Range | 7.49 - 14.86 |
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires purpose-built heal...
Global Medical REIT (GMRE) has been struggling lately, but the selling pressure may be coming to an end soon.
Global Medical REIT has preferred shares outstanding with a high coupon rate. The asset and dividend coverage levels are fantastic.
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires purpose-built heal...
We Are Selling A Few REITs
There are acres and acres worth of common “stones” available out there. Some of them are obviously not worth picking up.
Skill and integrity of management is one of the most important aspects of a REIT. A large portion of my analysis goes into vetting management.
Profit by seeking cash flow where few others look.
Global Medical REIT Inc. (GMRE) CEO Jeff Busch on Q3 2020 Results - Earnings Call Transcript
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 9.52% and 11.48%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires purpose-b...
Global Medical REIT has taken a road less travelled. It has stayed away from the ultra low capitalization rate medical office properties.
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires purpose-b...
The decline in elective procedures has lowered the share prices of REITs that specialize in medical office space.
According to the GuruFocus All-in-One Screener, a Premium feature, the stocks of the following guru-owned real estate companies have outperformed the S&P 500 Index over the past 12 months thro...
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc.
On August 6, 2020, GMRE published its Q2 figures, which beat the consensus expectations and sent the stock higher by 7.2%.
Global Medical REIT Inc. (GMRE) CEO Jeff Busch on Q2 2020 Results - Earnings Call Transcript
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc.
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc.
Medical Office Building REITs enjoy exceptionally high tenant rent coverage that dwarf other asset classes in healthcare.
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires purpose-b...
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires purpose-built heal...
Global Medical REIT Inc. (GMRE) CEO Jeff Busch on Q1 2020 Results - Earnings Call Transcript
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0.00% and 2.91%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Today we dive into 3 cheap stocks trading under $20 a share that also pay a dividend. Plus, the stocks we focused on are relatively immune from the current coronavirus economic downturn.
Global Medical REIT: An Unwarranted Divergence From The Peers
Top Ranked Income Stocks to Buy for April 9th
Global Medical REIT (GMRE) CEO, Jeffrey Busch on Q4 2019 Results - Earnings Call Transcript
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 5.00% and 5.23%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
5 REITs To Watch Closely In 2020
3 Small-Cap REITs That Are Set To Outperform
Global Medical REIT's (GMRE) CEO Jeff Busch on Q3 2019 Results - Earnings Call Transcript
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0.00% and 2.91%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
2CHYP's 8.4% dividend yield is supported by high cash flow yields.
Global Medical REIT Inc. (GMRE) CEO Jeff Busch on Q2 2019 Results - Earnings Call Transcript
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -5.26% and 0.81%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
GMRE has quietly remained in secondary and tertiary markets taking advantage of evolving trends in how medical care is being provided.
Global Medical REIT Inc. (GMRE) CEO Jeff Busch on Q1 2019 Results - Earnings Call Transcript
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -15.00% and -0.78%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
GMRE earnings call for the period ending December 31, 2018.
About GMRE
Global Medical REIT is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
| Industry REIT-Healthcare Facilities | |
| CEO Jeffrey Busch | Country United States |
| Stock Exchange NYSE | Ticker Symbol GMRE |
Financial Performance
In 2019, GMRE's revenue was $70.73 million, an increase of 32.96% compared to the previous year's $53.19 million. Earnings were $9.23 million, a decrease of -31.55%.
Analyst Forecasts
According to 8 analysts, the average rating for GMRE stock is "Strong Buy." The 12-month stock price forecast is 15.69, which is an increase of 18.68% from the latest price.